Skip to main content

Bayer Supervisory Board To Take Action On Roundup Claims

Bayer Supervisory Board To Take Action On Roundup Claims

Bayer Supervisory Board To Take Action On Roundup Claims

Introduction

Bayer issued a press release on June 26, announcing that it is rethinking its strategy over Roundup lawsuits and has hired legal help to guide the company’s management of the cases.

According to the press release issued, Bayer’s supervisory board established a new committee to “intensely monitor” the Roundup litigation. The committee is composed of shareholders, employee representatives, and supervisory board members. The board has also retained attorney John H. Beisner to advise on handling the mass tort litigation and the mediation process, which according to a federal judge would help avoid the need for thousands of individual cases.

Bayer still continues to maintain that glyphosate is safe, following the pressure mounting on the company to reach settlements for Roundup claims and investors pushing the company to identify alternative weedkillers. Bayer suffered three high-profile losses,  a $78 million verdict last summer, an $80 million verdict earlier this year, and a landmark $2 billion verdict last month, to individuals diagnosed with cancer following Roundup exposure.

Bayer and its Monsanto subsidiary, which was acquired one year ago, now face more than 15,000 Roundup lawsuits. U.S. District Judge Vince Chhabria is presiding over all the federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!